Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Jan 19;19(2):475. doi: 10.1158/1055-9965.EPI-09-0712

Table 1.

Characteristics of 311 endometrial cancer cases and 570 controls (nested within the California Teachers Study)

Characteristics Categories Cases
N (%)
Controls
N (%)
P Value*
Age <55 28 (9.0) 54 (9.5)
55–59 58 (18.6) 100 (17.5)
60–64 63 (20.3) 101 (17.7)
65–69 54 (17.4) 110 (19.3)
70–74 55 (17.7) 108 (18.9)
75+ 53 (17.0) 97 (17.0)

Race White 300 (96.5) 525 (92.1)
African American 2 (0.6) 9 (1.6)
Hispanic 3 (1.0) 17 (3.0)
Other 6 (1.9) 19 (3.3)

Menopause Type Natural 205 (65.9) 391 (68.6)
First HT Use 100 (32.2) 167 (29.3)
Other 6 (1.9) 12 (2.1) 0.75

Menopause Age <47 55 (17.7) 102 (17.9)
47–49 57 (18.3) 125 (21.9)
50–52 91 (29.3) 192 (33.7)
53–55 74 (23.8) 115 (20.2)
56+ 34 (10.9) 36 (6.3) 0.033

Menarche Age <12 64 (20.6) 99 (17.4)
12 78 (25.1) 162 (28.4)
13 104 (33.4) 180 (31.6)
14+ 65 (20.9) 129 (22.6) 0.58

BMI <25 142 (45.7) 336 (58.9)
25–29 93 (29.9) 163 (28.6)
30–34 48 (15.4) 51 (8.9)
35+ 28 (9.0) 20 (3.5) <0.001

Parity Nulliparous 75 (24.1) 108(18.9)
Parous 236 (75.9) 462 (81.1) 0.092

Number of Full-Term
Pregnancies
0 75 (24.1) 108 (18.9)
1 40 (12.9) 70 (12.3)
2 95 (30.5) 173 (30.4)
3 72 (23.2) 145 (25.4)
4+ 29 (9.3) 74 (13.0) 0.19

Age at Last full-Term
Pregnancy
<25 25 (10.6) 42 (9.1)
25–29 92 (39.0) 149 (32.3)
30–34 85 (36.0) 178 (38.5)
35+ 34 (14.4) 93 (20.1) 0.053

OC Use Never Use 187 (60.1) 298 (52.3)
<5y 69 (22.2) 120 (21.1)
5–9y 37 (11.9) 70 (12.3)
10–14y 9 (2.9) 39 (6.8)
15+y 9 (2.9) 43 (7.5) <0.001
*

Multivariate logistic regression models adjusted for matching factors (age, race, geographic area of residence, and reference year)

Additionally, adjusted for total number of full-term pregnancies

Abbreviations: BMI: Body Mass Index; OC: Oral Contraceptive